Document series
Trial abstracts — page 27
700 structured trial abstracts. Each is one document in five parts: abstract, design and population, results, certainty assessment and citing documents.
Showing 0 records on this page
Trial records
700 documents · page 27 of 30
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| HEX-PH2-ELDERLY-BODY-COMPprogramme record | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| HEX-PH2-ELDERLY-ELDERLYprogramme record | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| HEX-PH2-ELDERLY-QOLprogramme record | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| HEX-PH2-ELDERLY-REGIONAL-CNprogramme record | Hexarelin | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| HEX-PH2-ELDERLY-REGIONAL-JPprogramme record | Hexarelin | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| GHRP6-PH1-GH-ADHERENCEprogramme record | GHRP-6 | Phase 1 | Reported | Observational | — | 1995 | Very low |
| GHRP6-PH1-GH-BIOMARKERprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| GHRP6-PH1-GH-ELDERLYprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| GHRP6-PH1-GH-OLEprogramme record | GHRP-6 | Phase 1 | Reported | Single-arm open-label | — | 1995 | Very low |
| GHRP6-PH1-GH-QOLprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| HEX-PH1-GH-DDIprogramme record | Hexarelin | Phase 1 | Reported | Randomised crossover | — | 1995 | Very low |
| HEX-PH1-GH-HEPATIC-IMPprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| HEX-PH1-GH-OLEprogramme record | Hexarelin | Phase 1 | Reported | Single-arm open-label | — | 1995 | Very low |
| HEX-PH1-GH-PKprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| HEX-PH1-GH-RENAL-IMPprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| AMY-PH1-ORALprogramme record | Cagrilintide | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| AMY-PH1B-SCprogramme record | Cagrilintide | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| BPC-PH2-UC-BODY-COMPprogramme record | BPC-157 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| BPC-PH2-UC-QOLprogramme record | BPC-157 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| BPC-PH2-UC-REGIONAL-CNprogramme record | BPC-157 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| BPC-PH2-UC-REGIONAL-JPprogramme record | BPC-157 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| DREAMS-3-BODY-COMPprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| DREAMS-3-REGIONAL-CNprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| DREAMS-3-REGIONAL-JPprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
page 27 of 30